XOMA Royalty Corp.
NASDAQ:XOMA · NASDAQ Global Market
+$0.19 today
Vol 0.09M · Avg 0.21M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+59.76%
Period High
$42.40
Period Low
$22.89
Latest
$41.89
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Design Therapeutics, Inc.
NASDAQ:DSGN
$759.79M
Solid Biosciences Inc.
NASDAQ:SLDB
$591.34M
Autolus Therapeutics plc
NASDAQ:AUTL
$407.20M
Aura Biosciences, Inc.
NASDAQ:AURA
$398.68M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$350.51M
Benitec Biopharma Inc.
NASDAQ:BNTC
$316.28M
DiaMedica Therapeutics Inc.
NASDAQ:DMAC
$307.94M
I-Mab
IMAB
$235.66M
Quantum-Si incorporated
NASDAQ:QSI
$191.16M
Galectin Therapeutics Inc.
NASDAQ:GALT
$182.71M
What is the latest XOMA filing?
The latest filing shown is DEFA14A dated Jun 12, 2026.
How many recent filings does XOMA have?
Intrinsic Alpha currently shows 20 recent filings for XOMA.
Explore More
Continue the stock analysis
Jump to another research area for this company.